BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1773587)

  • 21. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
    Hasselbalch H; Lisse I
    Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
    Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
    Talarico L; Wolf BC; Kumar A; Weintraub LR
    Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis.
    Lahtinen R; Lahtinen T; Romppanen T
    J Nucl Med; 1982 Mar; 23(3):218-24. PubMed ID: 6950031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myelofibrosis.
    Rupani M
    Am J Clin Pathol; 1982 Apr; 77(4):475-8. PubMed ID: 6951405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)].
    Hernandez Nieto L; Morey Sureda M; Granena A; Montserrat Costa E; Feliu E; Rozman C
    Nouv Rev Fr Hematol (1978); 1979; 21(3):251-6. PubMed ID: 296376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V
    Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiological, hematologic and histologic analysis of myelo-osteosclerosis].
    Pawelski S; Kolakowski L; Pawlikowski J; Mietkowska I; Sielczak M
    Acta Haematol Pol; 1972; 3(2):101-9. PubMed ID: 4655610
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.
    Boveri E; Passamonti F; Rumi E; Pietra D; Elena C; Arcaini L; Pascutto C; Castello A; Cazzola M; Magrini U; Lazzarino M
    Br J Haematol; 2008 Jan; 140(2):162-8. PubMed ID: 18028479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
    Bedekovics J; Méhes G
    Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of myelofibrosis in dogs.
    Reagan WJ
    Toxicol Pathol; 1993; 21(2):164-9. PubMed ID: 8210938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Mäkitie RE; Niinimäki R; Kakko S; Honkanen T; Kovanen PE; Mäkitie O
    Osteoporos Int; 2018 Feb; 29(2):479-487. PubMed ID: 29147753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis in chronic myeloproliferative diseases.
    Di Raimondo F; Palumbo GA; Molica S; Giustolisi R
    Acta Haematol; 2001; 106(4):177-83. PubMed ID: 11815715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update.
    Thiele J; Kvasnicka HM; Fischer R; Diehl V
    Leuk Lymphoma; 1997 Feb; 24(5-6):463-81. PubMed ID: 9086437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelofibrosis in myeloproliferative disorders.
    Srinivasan U; Talvalkar GV; Advani SH
    Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
    [No Abstract]   [Full Text] [Related]  

  • 39. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
    Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H
    Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.